statistiche ricercatore

Nome	#
Identification and Biological Characterization of the Pyrazolo[3,4-d]pyrimidine Derivative SI388 Active as Src Inhibitor	76
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma	70
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment	68
4,6-Diphenyl-pyridines/pyrimidines and pyrazolo[3,4-d]pyrimidines: promising scaffolds as antiviral, anticancer and theranostic agents.	67
Synthesis of a new series of optimized pyrazolo[3,4‑d]pyrimidines as Src Inhibitors	59
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment	54
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma	51
Development of a new potential theranostic prodrug for targeting glioblastoma multiforme	50
Synthesis of hybrid small molecules as potential PA-PB1 heterodimer disruptors of Influenza virus Polymerase	50
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction	47
SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW 4-AMINO-PYRAZOLO[3,4-d]PYRIMIDINES AS POTENTIAL SRC KINASE INHIBITORS	44
Synthesis of a new generation of potential anti-influenza agents targeting the PA-PB1 protein-protein interaction.	44
New potential anti-flu agents acting by disrupting the PA-PB1 interaction of viral polymerase.	42
Totale	722

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	51	0	0	0	0	0	8	4	14	14	3	2	6
2022/2023	117	8	0	1	1	10	16	0	7	18	12	33	11
2023/2024	146	6	7	3	24	22	8	12	7	8	18	19	12
2024/2025	261	3	19	10	4	37	41	23	45	5	20	23	31
2025/2026	147	48	10	74	15	0	0	0	0	0	0	0	0
Totale													722